ATRO three-lens brief
Evidence-based stock research on ATRO. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved -2.69% yesterday. · 50-day MA below 200-day MA (death-cross regime); price below both.
- Moved -2.69% yesterday.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Underperforming SPY by 10.1pp over 30 days.
- Analyst mean target $91.75 — 52% above current (4 analysts).
- Reported earnings on 2026-11-10.
ATRO closed at $60.33 (-2.69%) as of 2026-11-12. Market cap: $2.59B. P/E (trailing) 19.8. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $91.75 — 52% above current (4 analysts).. Concerns: moved -2.69% yesterday.; 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $271.68M, net income $52.20M, free cash flow $31.17M.
Why three lenses on ATRO, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ATRO across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/ATRO" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ATRO brief"></iframe>